Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more
Semler Scientific Inc (SMLR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.072x
Based on the latest financial reports, Semler Scientific Inc (SMLR) has a cash flow conversion efficiency ratio of -0.072x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-32.95 Million) by net assets ($459.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Semler Scientific Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Semler Scientific Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Semler Scientific Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Semler Scientific Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
0.077x |
|
SK Networks Co Ltd
KO:001740
|
0.035x |
|
Marcus Corporation
NYSE:MCS
|
0.086x |
|
Agora Inc
NASDAQ:API
|
0.017x |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
N/A |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
0.007x |
|
ThredUp Inc
NASDAQ:TDUP
|
0.102x |
|
Hubei Sanxia New Building Materials Co Ltd
SHG:600293
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Semler Scientific Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Semler Scientific Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $230.75 Million | $24.41 Million | 0.106x | -57.38% |
| 2023-12-31 | $71.80 Million | $17.82 Million | 0.248x | -20.87% |
| 2022-12-31 | $55.68 Million | $17.46 Million | 0.314x | -11.02% |
| 2021-12-31 | $45.55 Million | $16.06 Million | 0.353x | -30.51% |
| 2020-12-31 | $29.79 Million | $15.11 Million | 0.507x | -47.89% |
| 2019-12-31 | $13.07 Million | $12.73 Million | 0.974x | -13.02% |
| 2018-12-31 | $4.20 Million | $4.70 Million | 1.119x | +565.61% |
| 2017-12-31 | $-2.58 Million | $621.00K | -0.240x | -138.90% |
| 2016-12-31 | $-2.92 Million | $-1.80 Million | 0.618x | -83.98% |
| 2015-12-31 | $-1.07 Million | $-4.13 Million | 3.857x | +446.77% |
| 2014-12-31 | $3.44 Million | $-3.82 Million | -1.112x | -127.53% |
| 2013-12-31 | $-295.00K | $-1.19 Million | 4.041x | +693.27% |
| 2012-12-31 | $-3.58 Million | $-1.82 Million | 0.509x | -81.26% |
| 2011-12-31 | $-469.00K | $-1.27 Million | 2.719x | -- |